Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Bhlhb8 | |
NM_010800 |
basic helix-loop-helix domain containing, class B, 8 (Bhlhb8), mRNA [NM_010800] |
KLA | .97 |
1.03 |
1.06 |
1.04 |
1.04 |
1.04 |
1.06 |
| ATP | 1.01 |
1.01 |
1.00 |
1.07 |
1.06 |
1.03 |
1.02 |
| KLA/ATP | 1.04 |
1.02 |
1.08 |
1.10 |
1.00 |
1.04 |
.98 |
|
Foxa2 | |
NM_010446 |
forkhead box A2 (Foxa2), mRNA [NM_010446] |
KLA | .98 |
1.01 |
1.00 |
.99 |
1.01 |
1.00 |
1.02 |
| ATP | .99 |
.99 |
1.02 |
1.01 |
.99 |
1.01 |
1.00 |
| KLA/ATP | 1.01 |
.99 |
1.02 |
1.01 |
1.00 |
.98 |
.99 |
|
Foxa3 | |
NM_008260 |
forkhead box A3 (Foxa3), mRNA [NM_008260] |
KLA | 1.00 |
.93 |
.99 |
.99 |
.98 |
1.00 |
1.01 |
| ATP | .93 |
.99 |
1.06 |
.99 |
1.03 |
.98 |
1.03 |
| KLA/ATP | .95 |
1.05 |
1.05 |
1.01 |
.96 |
1.04 |
1.04 |
|
Gck | |
NM_010292 |
glucokinase (Gck), mRNA [NM_010292] |
KLA | 1.03 |
.99 |
1.04 |
1.02 |
.97 |
.98 |
1.00 |
| ATP | 1.01 |
.97 |
1.08 |
.99 |
1.06 |
.98 |
.96 |
| KLA/ATP | 1.06 |
1.01 |
.96 |
.98 |
.98 |
1.01 |
1.01 |
|
Hes1 | |
NM_008235 |
hairy and enhancer of split 1 (Drosophila) (Hes1), mRNA [NM_008235] |
KLA | .96 |
1.00 |
1.02 |
.93 |
1.01 |
.94 |
.99 |
| ATP | .93 |
1.03 |
1.05 |
.96 |
1.06 |
1.02 |
1.02 |
| KLA/ATP | .97 |
.93 |
1.03 |
1.06 |
1.10 |
1.17 |
1.16 |
|
Hhex | |
NM_008245 |
hematopoietically expressed homeobox (Hhex), mRNA [NM_008245] |
KLA | 1.79 |
1.67 |
1.40 |
.64 |
.47 |
1.02 |
.64 |
| ATP | .97 |
1.04 |
1.01 |
.74 |
.34 |
.36 |
.60 |
| KLA/ATP | 1.63 |
1.58 |
1.79 |
1.12 |
.49 |
.44 |
.34 |
|
Hnf1a | |
M57966 |
gb|Mouse hepatocyte nuclear factor 1 (HNF-1) mRNA, complete cds [M57966] |
KLA | 1.01 |
1.00 |
.97 |
1.02 |
1.04 |
.99 |
1.01 |
| ATP | .99 |
1.04 |
1.02 |
.96 |
.98 |
.96 |
1.13 |
| KLA/ATP | 1.03 |
.97 |
1.02 |
1.01 |
.90 |
.94 |
1.04 |
|
Hnf1b | |
NM_009330 |
HNF1 homeobox B (Hnf1b), mRNA [NM_009330] |
KLA | 1.10 |
1.11 |
1.10 |
1.10 |
1.08 |
1.11 |
1.02 |
| ATP | 1.02 |
1.01 |
1.04 |
1.03 |
1.02 |
1.06 |
1.10 |
| KLA/ATP | 1.08 |
1.03 |
1.06 |
1.19 |
1.13 |
1.03 |
1.05 |
|
Hnf4a | |
NM_008261 |
hepatic nuclear factor 4, alpha (Hnf4a), mRNA [NM_008261] |
KLA | 1.00 |
1.02 |
.98 |
1.02 |
.99 |
.99 |
1.03 |
| ATP | 1.01 |
1.03 |
1.00 |
.95 |
.93 |
1.04 |
1.00 |
| KLA/ATP | 1.03 |
1.02 |
1.08 |
.98 |
.98 |
.99 |
.97 |
|
Hnf4g | |
AK136534 |
adult male cecum cDNA, RIKEN full-length enriched library, clone:9130202K07 product:hypothetical protein, full insert sequence [AK136534] |
KLA | 1.08 |
1.06 |
1.05 |
1.02 |
.94 |
1.01 |
1.03 |
| ATP | .99 |
1.03 |
.97 |
.96 |
1.03 |
1.00 |
1.02 |
| KLA/ATP | .99 |
1.10 |
1.00 |
.99 |
1.02 |
.98 |
1.01 |
|
Hnf4g | |
NM_013920 |
hepatocyte nuclear factor 4, gamma (Hnf4g), mRNA [NM_013920] |
KLA | 1.00 |
.95 |
.95 |
.99 |
1.01 |
.96 |
.99 |
| ATP | .95 |
1.01 |
1.06 |
.95 |
.95 |
1.07 |
1.04 |
| KLA/ATP | .95 |
.92 |
.96 |
1.01 |
.99 |
.93 |
.97 |
|
Ins1 | |
NM_008386 |
insulin I (Ins1), mRNA [NM_008386] |
KLA | 1.00 |
.99 |
.99 |
1.03 |
1.01 |
.98 |
1.06 |
| ATP | .97 |
1.03 |
1.00 |
1.03 |
.99 |
1.07 |
1.05 |
| KLA/ATP | 1.03 |
.93 |
.98 |
1.04 |
1.07 |
1.03 |
1.01 |
|
Ins2 | |
NM_008387 |
insulin II (Ins2), mRNA [NM_008387] |
KLA | .99 |
1.00 |
1.00 |
1.01 |
1.00 |
1.02 |
1.00 |
| ATP | 1.01 |
.99 |
1.00 |
1.00 |
.98 |
.99 |
1.01 |
| KLA/ATP | .99 |
1.01 |
1.00 |
.98 |
.99 |
.99 |
.98 |
|
Mafa | |
NM_194350 |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) (Mafa), mRNA [NM_194350] |
KLA | 1.01 |
1.00 |
.97 |
1.01 |
.99 |
.98 |
1.10 |
| ATP | .98 |
1.08 |
1.08 |
1.11 |
1.04 |
.99 |
1.00 |
| KLA/ATP | 1.00 |
1.02 |
.96 |
1.22 |
1.13 |
1.07 |
1.00 |
|
Mm.33260 7 | |
166295201 |
Unknown |
KLA | 1.03 |
1.09 |
1.04 |
1.04 |
1.03 |
.98 |
.99 |
| ATP | 1.03 |
1.04 |
.99 |
1.02 |
.97 |
1.03 |
1.00 |
| KLA/ATP | .96 |
.99 |
.88 |
1.08 |
1.07 |
.92 |
1.01 |
|
Mm.415 | |
162135961 |
Unknown |
KLA | 1.01 |
1.01 |
1.05 |
.96 |
1.00 |
.94 |
.97 |
| ATP | 1.06 |
.96 |
1.02 |
1.07 |
.99 |
.97 |
1.01 |
| KLA/ATP | 1.03 |
1.03 |
.99 |
.98 |
.97 |
1.00 |
1.01 |
|
Mnx1 | |
NM_019944 |
motor neuron and pancreas homeobox 1 (Mnx1), mRNA [NM_019944] |
KLA | .97 |
1.01 |
.98 |
1.08 |
1.01 |
1.03 |
1.03 |
| ATP | 1.03 |
1.01 |
1.01 |
1.03 |
.98 |
1.01 |
1.08 |
| KLA/ATP | 1.07 |
.93 |
1.22 |
1.03 |
1.04 |
1.04 |
1.04 |
|
Neurod1 | |
NM_010894 |
neurogenic differentiation 1 (Neurod1), mRNA [NM_010894] |
KLA | 1.00 |
1.05 |
.98 |
1.03 |
1.01 |
.93 |
.98 |
| ATP | .96 |
1.01 |
1.05 |
1.06 |
1.00 |
1.01 |
1.04 |
| KLA/ATP | .87 |
1.00 |
1.09 |
1.02 |
1.01 |
.96 |
1.02 |
|
Neurog3 | |
NM_009719 |
neurogenin 3 (Neurog3), mRNA [NM_009719] |
KLA | .99 |
.99 |
1.02 |
1.02 |
1.01 |
1.05 |
1.04 |
| ATP | .98 |
1.07 |
1.07 |
1.00 |
1.00 |
.95 |
1.04 |
| KLA/ATP | 1.02 |
1.03 |
1.01 |
1.08 |
.96 |
.95 |
.99 |
|
Nkx2-2 | |
NM_010919 |
NK2 transcription factor related, locus 2 (Drosophila) (Nkx2-2), transcript variant 1, mRNA [NM_010919] |
KLA | 1.00 |
.93 |
.99 |
1.02 |
.96 |
1.03 |
1.00 |
| ATP | 1.03 |
.96 |
.98 |
.97 |
.97 |
.96 |
.98 |
| KLA/ATP | 1.00 |
1.02 |
1.00 |
.96 |
.95 |
1.00 |
.95 |
|
Nkx6-1 | |
NM_144955 |
NK6 transcription factor related, locus 1 (Drosophila) (Nkx6-1), mRNA [NM_144955] |
KLA | 1.24 |
1.14 |
1.23 |
1.20 |
1.23 |
1.16 |
1.24 |
| ATP | 1.04 |
1.09 |
1.02 |
1.12 |
1.12 |
1.25 |
1.19 |
| KLA/ATP | 1.25 |
1.25 |
1.25 |
1.30 |
1.06 |
1.09 |
1.19 |
|
Nr5a2 | |
NM_030676 |
nuclear receptor subfamily 5, group A, member 2 (Nr5a2), mRNA [NM_030676] |
KLA | 1.02 |
.96 |
.97 |
1.03 |
1.04 |
.99 |
1.05 |
| ATP | .98 |
1.01 |
.94 |
.95 |
1.01 |
1.01 |
.98 |
| KLA/ATP | 1.03 |
1.01 |
.96 |
.97 |
1.04 |
1.06 |
1.01 |
|
Onecut1 | |
AK051235 |
12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130020G02 product:DNA segment, Chr 9, ERATO Doi 423, expressed, full insert sequence. [AK051235] |
KLA | 1.06 |
.94 |
.93 |
1.01 |
.97 |
1.07 |
.97 |
| ATP | 1.00 |
.96 |
.99 |
.95 |
.96 |
.99 |
.97 |
| KLA/ATP | 1.00 |
1.01 |
1.05 |
.99 |
.91 |
.97 |
1.06 |
|
Onecut1 | |
NM_008262 |
one cut domain, family member 1 (Onecut1), mRNA [NM_008262] |
KLA | .96 |
1.01 |
.99 |
.99 |
1.00 |
1.01 |
.94 |
| ATP | .98 |
.98 |
.96 |
.98 |
1.02 |
1.04 |
.96 |
| KLA/ATP | .97 |
.92 |
.94 |
1.04 |
1.02 |
.96 |
.97 |
|
Pax4 | |
NM_011038 |
paired box gene 4 (Pax4), mRNA [NM_011038] |
KLA | 2.67 |
2.35 |
2.19 |
1.43 |
1.13 |
1.09 |
1.07 |
| ATP | 1.05 |
.99 |
1.14 |
1.06 |
1.05 |
.96 |
1.04 |
| KLA/ATP | 2.71 |
2.99 |
2.34 |
2.10 |
1.45 |
1.11 |
.97 |
|
Pax6 | |
AK139054 |
7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730006J20 product:paired box gene 6, full insert sequence [AK139054] |
KLA | .90 |
.98 |
.99 |
.94 |
.99 |
1.05 |
.91 |
| ATP | .98 |
1.03 |
.94 |
.93 |
1.02 |
.96 |
.95 |
| KLA/ATP | 1.03 |
1.15 |
.96 |
.94 |
1.01 |
.97 |
.97 |
|
Pax6 | |
NM_013627 |
paired box gene 6 (Pax6), mRNA [NM_013627] |
KLA | 1.03 |
1.03 |
1.03 |
1.04 |
1.02 |
1.02 |
1.03 |
| ATP | 1.01 |
.99 |
1.09 |
1.11 |
1.19 |
1.18 |
1.04 |
| KLA/ATP | 1.02 |
1.06 |
1.27 |
1.31 |
1.13 |
1.28 |
1.19 |
|
Pdx1 | |
NM_008814 |
pancreatic and duodenal homeobox 1 (Pdx1), mRNA [NM_008814] |
KLA | .92 |
1.07 |
1.11 |
1.03 |
1.02 |
1.09 |
1.06 |
| ATP | 1.08 |
1.02 |
1.02 |
1.03 |
1.09 |
1.07 |
1.01 |
| KLA/ATP | 1.03 |
1.12 |
.86 |
1.08 |
1.27 |
1.11 |
1.13 |
|
Pklr | |
NM_013631 |
pyruvate kinase liver and red blood cell (Pklr), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_013631] |
KLA | 1.06 |
1.01 |
1.12 |
1.00 |
.98 |
1.01 |
1.07 |
| ATP | .98 |
.94 |
1.05 |
1.06 |
1.01 |
1.06 |
1.10 |
| KLA/ATP | .97 |
1.00 |
1.04 |
.95 |
.89 |
1.05 |
.97 |
|
Slc2a2 | |
NM_031197 |
solute carrier family 2 (facilitated glucose transporter), member 2 (Slc2a2), mRNA [NM_031197] |
KLA | 1.01 |
1.03 |
.97 |
1.00 |
1.01 |
1.02 |
1.04 |
| ATP | 1.02 |
.97 |
1.07 |
1.00 |
1.00 |
1.03 |
1.00 |
| KLA/ATP | 1.01 |
1.01 |
.95 |
1.00 |
1.05 |
1.02 |
1.01 |
|